Synchronous ovarian and endometrial malignancies

Area of Science:

• Gynecology
• Oncology
• Pathology

Background:

• Synchronous primary tumors of the endometrium and ovary are uncommon.
• Previous studies often included cases of similar histology, potentially misrepresenting metastases as independent primaries.
• Distinguishing between independent primaries and metastases is crucial for accurate diagnosis and treatment.

Purpose of the Study:

• To investigate the characteristics and outcomes of patients with synchronous endometrial and ovarian primaries of dissimilar histology.
• To differentiate true synchronous primaries from metastatic disease in the ovary.
• To evaluate the prognostic factors influencing survival in this specific patient group.

Main Methods:

• Retrospective review of 499 patients with endometrial cancer undergoing surgery (1980-1997).
• Identification of 18 patients (3.6%) with synchronous endometrial and ovarian primaries of dissimilar histology.
• Analysis of patient demographics, tumor characteristics (stage, grade, histology), and survival data (disease-free survival, cause-specific survival).

Main Results:

• The median age of affected women was 64.2 years.
• Most patients presented with early-stage (Stage I), low-grade (Grade I-II) endometrial adenocarcinomas and Stage IA ovarian cystadenocarcinomas (mucinous or serous).
• The 5-year disease-free survival was 81.2%, and cause-specific survival was 89.5%. Patients with Stage I disease in both organs showed a trend towards better DFS (100% vs. 68.6%).

Conclusions:

• Synchronous ovarian primaries of dissimilar histology are rare in endometrial cancer patients.
• These patients are typically older and present with early-stage, low-grade disease in both the endometrium and ovary.
• The overall prognosis is favorable, particularly for those with early-stage disease in both primary sites, suggesting distinct biological behavior.